Director, Regulatory Affairs Strategy - Cardiovascular/Metabolic
Regeneron Pharmaceuticals
About this role
The Director Regulatory Affairs Strategy provides leadership on global regulatory activities for pharmaceutical products, focusing on clinical regulatory filings, including IND/CTA and BLA submissions. The role involves strategic planning, regulatory interpretation, and collaboration with various teams to ensure compliance and successful approvals.
Skills
Qualifications
About Regeneron Pharmaceuticals
regeneron.comDiscover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Recent company news
Regeneron Pharmaceuticals, Inc. $REGN Shares Acquired by South Dakota Investment Council
8 hours ago
Regeneron Pharmaceuticals (Nasdaq:REGN) - Stock Analysis
2 days ago
Here’s Why Regeneron Stock Could Deliver 60% Upside Returns
11 hours ago
Why Regeneron Pharmaceuticals (REGN) is One of the Top Gene Therapy Stocks to Buy According to Hedge Funds
4 days ago
Regeneron Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
1 day ago
About Regeneron Pharmaceuticals
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Salary
$205k – $342k
per year